Sartorius Stedim Biotech (SSB) and Repligen Corp., a global life sciences company focused on bioprocessing technologies, have entered into a collaboration to integrate Repligen’s XCell ATF cell retention control technology into SSB’s BIOSTAT STR large-scale single-use bioreactors to create novel perfusion-enabled bioreactors. The collaboration will result in a single control system for 50 L to 2,000 L bioreactors for use in perfusion cell culture applications. This single interface is designed t...